RxDoctor Payments Data

Kimberly Stanley

Family · Mantachie, MSNPI 1770824955

Payments from drug & device makers

$808in general payments, 2019–2025

Across 45 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$152
  • Bayer$124
  • AbbVie$109
  • Novo Nordisk$86
  • Sequel Med Tech, LLC$80
  • Corcept Therapeutics$77
  • plus $179 from 8 others

What the payments were for

  • Food & beverage$808100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$808 in reported general payments places this provider in the 60th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$47,106
Medicare patients
188
Services billed
1,990

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide50$80,858
JardianceEmpagliflozin53$60,232
OzempicSemaglutide46$60,109
FarxigaDapagliflozin Propanediol35$32,854
EliquisApixaban20$27,539
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$13,213
Tresiba Flextouch U-200Insulin Degludec14$12,945
Gabapentin90$1,777
SynthroidLevothyroxine Sodium20$1,329
Omeprazole104$1,267
Albuterol Sulfate HfaAlbuterol Sulfate31$1,031
Aripiprazole12$950
Famotidine53$824
Buspirone Hcl45$703
Pantoprazole Sodium58$663

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$49$80,85850 claims
Boehringer IngelheimJardiance$14$60,23253 claims
Novo NordiskOzempic$86$60,10946 claims
AstraZenecaFarxiga$152$32,85435 claims
GSKTrelegy Ellipta$15$13,21311 claims
AbbVieSynthroid$109$1,32920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,007 family providers in Mississippi.

Other family in Mantachie

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →